These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 27162217)

  • 21. Newer-Generation Devices for Transcatheter Aortic Valve Replacement: Resolving the Limitations of First-Generation Valves?
    Pilgrim T; Windecker S
    JACC Cardiovasc Interv; 2016 Feb; 9(4):373-375. PubMed ID: 26892083
    [No Abstract]   [Full Text] [Related]  

  • 22. The alternative approach to transcatheter aortic valve replacement.
    Kornowski R
    Catheter Cardiovasc Interv; 2016 Feb; 87(2):339-40. PubMed ID: 26876512
    [No Abstract]   [Full Text] [Related]  

  • 23. Utilization and Mortality Trends in Transcatheter and Surgical Aortic Valve Replacement: The New York State Experience--2011 to 2012.
    Hermiller J; Sampson AJ
    JACC Cardiovasc Interv; 2016 Mar; 9(6):586-8. PubMed ID: 27013158
    [No Abstract]   [Full Text] [Related]  

  • 24. Highway to the heart or one more for the road? The continued life of direct aortic access for transcatheter aortic valve replacement.
    Reardon MJ; Kleiman NS
    J Thorac Cardiovasc Surg; 2016 Dec; 152(6):1616-1617. PubMed ID: 27566890
    [No Abstract]   [Full Text] [Related]  

  • 25. First-in-man transfemoral transcatheter aortic valve implantation with the ACURATE neo for the treatment of aortic regurgitation.
    Toggweiler S; Biaggi P; Grünenfelder J; Reho I; Bühler I; Corti R
    EuroIntervention; 2016 May; 12(1):78. PubMed ID: 27173866
    [No Abstract]   [Full Text] [Related]  

  • 26. Can We Predict Quality of Life and Survival After Transcatheter Aortic Valve Replacement?
    O'Sullivan CJ; Wenaweser P
    Circ Cardiovasc Interv; 2015 Dec; 8(12):e003347. PubMed ID: 26643742
    [No Abstract]   [Full Text] [Related]  

  • 27. Emergency interventions for the treatment of decompensated aortic stenosis.
    Adamson PD; Cruden N
    Heart; 2018 Jan; 104(1):4-5. PubMed ID: 28607163
    [No Abstract]   [Full Text] [Related]  

  • 28. Balloon aortic valvuloplasty in the transcatheter aortic valve replacement era: A challenge to organization of the heart team.
    Campante Teles R
    Rev Port Cardiol; 2017 Apr; 36(4):257-259. PubMed ID: 28318854
    [No Abstract]   [Full Text] [Related]  

  • 29. Treatment of Pure Aortic Regurgitation Using a Second-Generation Transcatheter Aortic Valve Implantation System.
    Zhu D; Wei L; Cheung A; Guo Y; Chen Y; Zhu L; Liu H; Yang Y; Zhang J; Wang C
    J Am Coll Cardiol; 2016 Jun; 67(23):2803-2805. PubMed ID: 27282902
    [No Abstract]   [Full Text] [Related]  

  • 30. The "hidden experiment": percutaneous vs. surgical cut-down for transfemoral transcatheter aortic valve implantation.
    Piazza N; Windecker S
    EuroIntervention; 2017 Mar; 12(16):1925-1926. PubMed ID: 28317785
    [No Abstract]   [Full Text] [Related]  

  • 31. Cardiac rehabilitation after transcatheter aortic valve implantation: Growing needs in a growing population.
    Pressler A
    Eur J Prev Cardiol; 2017 May; 24(7):685-687. PubMed ID: 28395538
    [No Abstract]   [Full Text] [Related]  

  • 32. Re: The impact of the development of transcatheter aortic valve implantation on the management of severe aortic stenosis in high-risk patients: treatment strategies and outcome.
    Svensson LG
    Eur J Cardiothorac Surg; 2017 Jan; 51(1):89-90. PubMed ID: 27582075
    [No Abstract]   [Full Text] [Related]  

  • 33. Transcatheter Aortic Valve Implantation for Chronic Dialysis Patients in Japan.
    Yamashita K; Taniguchi S
    Circ J; 2015; 79(12):2557-9. PubMed ID: 26538468
    [No Abstract]   [Full Text] [Related]  

  • 34. Paravalvular Regurgitation After Transcatheter Aortic Valve Replacement: Striving to Perfect its Prognostic Evaluation With Hemodynamic Data.
    Jilaihawi H
    JACC Cardiovasc Interv; 2016 Apr; 9(7):712-4. PubMed ID: 27056310
    [No Abstract]   [Full Text] [Related]  

  • 35. Letter by Grocott Regarding Article, "Evolution of Cognitive Function After Transcatheter Aortic Valve Implantation".
    Grocott HP
    Circ Cardiovasc Interv; 2017 Feb; 10(2):e004829. PubMed ID: 28183750
    [No Abstract]   [Full Text] [Related]  

  • 36. Let us preserve the harmonious development of transcatheter aortic valve implantation!
    Vahanian A; Nataf P
    Eur Heart J; 2016 Jul; 37(28):2249-51. PubMed ID: 27354055
    [No Abstract]   [Full Text] [Related]  

  • 37. Duration of antiplatelet or anticoagulant therapy after transcatheter aortic valve implantation in high risk patients; longer or shorter.
    Ozturk C; Celik T; Ozturk A; Balta S; Iyisoy A
    Int J Cardiol; 2016 May; 210():14-5. PubMed ID: 26922705
    [No Abstract]   [Full Text] [Related]  

  • 38. Comments on: Prognostic impact of anemia and iron-deficiency anemia in a contemporary cohort of patients undergoing transcatheter aortic valve implantation.
    Khazaei S; Hanis SM; Mansori K
    Int J Cardiol; 2018 Mar; 254():344. PubMed ID: 29407119
    [No Abstract]   [Full Text] [Related]  

  • 39. Peripheral artery disease and transcatheter aortic valve implantation: The tip of the atherosclerotic iceberg.
    Regazzoli D; Leone PP; Ancona MB; Colombo A
    Int J Cardiol; 2018 Mar; 255():213-214. PubMed ID: 29425563
    [No Abstract]   [Full Text] [Related]  

  • 40. Transcatheter aortic valve implantation: the optimal alternative to cardiac reoperation also from the patient's perspective.
    Amat-Santos IJ; Catalá P
    Kardiol Pol; 2018; 76(5):817-818. PubMed ID: 29756188
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.